Jens Ceder is a Nordic Disease Area Specialist in GU Oncology at AstraZeneca, focusing on precision oncology and targeted treatments. With a Ph.D. in Medical Science from Lund University, Jens has extensive experience in translational tumor biology and has successfully launched the first tumor-agnostic drug in the Nordics. Jens previously served as a Medical Advisor and Medical Science Liaison, engaging with key experts and supporting clinical studies in oncology. In addition to research roles at Lund University, Jens has contributed to scientific publications as a member of the Editorial Board for "Research and Reports in Urology."
This person is not in the org chart
This person is not in any teams
This person is not in any offices